PReS-FINAL-2027: Cerebral demyelination and optic neuritis during treatment with eternacept and methotrexate

Detalles Bibliográficos
Autores principales: Christensen, AE, Bistrup, L, Toftedal, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044739/
http://dx.doi.org/10.1186/1546-0096-11-S2-P40
_version_ 1782319198415880192
author Christensen, AE
Bistrup, L
Toftedal, P
author_facet Christensen, AE
Bistrup, L
Toftedal, P
author_sort Christensen, AE
collection PubMed
description
format Online
Article
Text
id pubmed-4044739
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40447392014-06-19 PReS-FINAL-2027: Cerebral demyelination and optic neuritis during treatment with eternacept and methotrexate Christensen, AE Bistrup, L Toftedal, P Pediatr Rheumatol Online J Poster Presentation BioMed Central 2013-12-05 /pmc/articles/PMC4044739/ http://dx.doi.org/10.1186/1546-0096-11-S2-P40 Text en Copyright © 2013 Christensen et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Christensen, AE
Bistrup, L
Toftedal, P
PReS-FINAL-2027: Cerebral demyelination and optic neuritis during treatment with eternacept and methotrexate
title PReS-FINAL-2027: Cerebral demyelination and optic neuritis during treatment with eternacept and methotrexate
title_full PReS-FINAL-2027: Cerebral demyelination and optic neuritis during treatment with eternacept and methotrexate
title_fullStr PReS-FINAL-2027: Cerebral demyelination and optic neuritis during treatment with eternacept and methotrexate
title_full_unstemmed PReS-FINAL-2027: Cerebral demyelination and optic neuritis during treatment with eternacept and methotrexate
title_short PReS-FINAL-2027: Cerebral demyelination and optic neuritis during treatment with eternacept and methotrexate
title_sort pres-final-2027: cerebral demyelination and optic neuritis during treatment with eternacept and methotrexate
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044739/
http://dx.doi.org/10.1186/1546-0096-11-S2-P40
work_keys_str_mv AT christensenae presfinal2027cerebraldemyelinationandopticneuritisduringtreatmentwitheternaceptandmethotrexate
AT bistrupl presfinal2027cerebraldemyelinationandopticneuritisduringtreatmentwitheternaceptandmethotrexate
AT toftedalp presfinal2027cerebraldemyelinationandopticneuritisduringtreatmentwitheternaceptandmethotrexate

Ejemplares similares